The tests are performing well, but are still being optimized. The biggest hold back at the moment is to scale from mass production (10s of 1000s of chips per month) to extreme mass production (10s of millions and, with time, 100s of millions of chips per month).

2021-10-07: This seems to have happened:

Covid-10 has driven a change in diagnostics technology. Many companies debuted new technologies for at-home test kits under the FDA emergency use authorization last year. “It’s going to go beyond Covid-19 testing. Everything from cancer detection to STD testing and anything that would go through the historical lab chain. We’ve gotten a lot of inquiries for rapid test kits from various companies about new applications. It’s going to be a revolution for the diagnostics market. To go from a test that would take 24-48 hours and cost $150 to get processed, to something you can do in 15 minutes for $20 or $30.”

• Uncategorized